NAFLD reduces NRF2 phosphorylation, prevents NRF2 nuclear translocation, and inhibits downstream antioxidant stress-related enzymes (Kang et al., 2022), including HO-1 and NQO-1. The gene discussed is HMOX1; the disease is metabolic dysfunction-associated steatotic liver disease.